title: GYKI-52466: a potential therapeutic agent for glutamate-mediated excitotoxic injury in Cerebral Palsy.
authors.forename: M S
authors.initials: MS
authors.lastname: Nandhu
authors.forename: Jes
authors.initials: J
authors.lastname: Paul
authors.forename: Jobin
authors.initials: J
authors.lastname: Mathew
authors.forename: T
authors.initials: T
authors.lastname: Peeyush Kumar
authors.forename: C S
authors.initials: CS
authors.lastname: Paulose
mesh_terms: D001569:Benzodiazepines / Q000008:administration & dosage*; D001927:Brain Diseases / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D002547:Cerebral Palsy / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism*; D018698:Glutamic Acid / Q000378:metabolism*; D006801:Humans; D008959:Models, Neurological; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors*
chemical_list: D018091:Receptors, AMPA; C061950:GYKI 52466; D001569:Benzodiazepines; D018698:Glutamic Acid